Company Filing History:
Years Active: 1995-2004
Title: Xavier Edmonds-Alt: Innovator in Neurokinin Receptor Antagonists
Introduction
Xavier Edmonds-Alt is a notable inventor based in Combaillaux, France. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target neurokinin receptors. With a total of two patents to his name, his work has implications for treating various pathologies.
Latest Patents
Edmonds-Alt's latest patents include "Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them" and "N-alkylenepiperidino compounds, their enantiomers and pharmaceutical compositions." These inventions focus on N-alkylenepiperidino compounds that serve as antagonists of neurokinin receptors, which are crucial in addressing substance P- and neurokinin-independent pathologies.
Career Highlights
Throughout his career, Xavier has worked with prominent companies in the pharmaceutical industry, including Elf Sanofi and Sanofi-Synthelabo. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Xavier has collaborated with notable professionals in his field, including Vincenzo Proietto and Didier Van Broeck. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Xavier Edmonds-Alt is a distinguished inventor whose work in neurokinin receptor antagonists has the potential to impact the treatment of various medical conditions. His patents and collaborations reflect his commitment to innovation in the pharmaceutical industry.